Trends in incidence, prevalence, and disability-adjusted life years of schizophrenia in China from 1990 to 2021, with projections for 2022-2050
GBD 2021 data reveal a rising SCZ burden in China, especially in ASPR and ASDR, posing increasing public health challenges. Males bore a consistently higher burden, but the female burden increased faster than the global average, highlighting gender-specific concerns. Age patterns emphasize young and middle-aged populations as key targets for intervention. Projected increases in incidence and mortality call for enhanced, tailored prevention and treatment strategies, improved resource allocation, and strengthened mental health services to mitigate the societal impact.
Authors
- Sha Zhu (ORCID: https://orcid.org/0000-0002-5395-4743)
- Qiqing Tan
- Rui Li (ORCID: https://orcid.org/0000-0002-6474-9702)
- Junjiao Ping (ORCID: https://orcid.org/0009-0001-6454-9444)
- Xiuying Hu (ORCID: https://orcid.org/0000-0003-1470-4108)
- Junyu Huo (ORCID: https://orcid.org/0000-0002-1345-1893)
- Aoxiang Luo
- Jing Chen (ORCID: https://orcid.org/0000-0002-2958-5546)
- Yanxin Xu (ORCID: https://orcid.org/0009-0006-0504-1524)
- Jing Wan (ORCID: https://orcid.org/0000-0001-6914-326X)
- Tingyun Jiang (ORCID: https://orcid.org/0009-0007-2165-3819)
- Xuan Ren (ORCID: https://orcid.org/0009-0006-9589-3412)
Institutions
- Guangdong Pharmaceutical University (CN)
- Zhongshan People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2025-09-04
- DOI
- https://doi.org/10.3389/fpsyt.2025.1651350
- Citations
- 2
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94